Long
IBOL
Idea only not professional advice
BIOLASE Reports 70% Revenue Growth In First Quarter 2021; Continued High Demand From New Users For Dental Lasers.
2021 First Quarter Operating Highlights (all comparisons are on a year over year basis):
Net revenue grew 70% to $8.1 million with:
Laser system sales increased 139%
Consumables and other revenue increased 52%
U.S. revenue increased 67%
International revenue increased 75%
The gross margin was 34%, up 500 basis points
Maintained a strong balance sheet, as cash and cash equivalents totaled $40.8 million on March 31, 2021, up from $17.6 million on December 31, 2020.
Good reports combined with volume entry, the direction seems to be up
BIOLASE Reports 70% Revenue Growth In First Quarter 2021; Continued High Demand From New Users For Dental Lasers.
2021 First Quarter Operating Highlights (all comparisons are on a year over year basis):
Net revenue grew 70% to $8.1 million with:
Laser system sales increased 139%
Consumables and other revenue increased 52%
U.S. revenue increased 67%
International revenue increased 75%
The gross margin was 34%, up 500 basis points
Maintained a strong balance sheet, as cash and cash equivalents totaled $40.8 million on March 31, 2021, up from $17.6 million on December 31, 2020.
Good reports combined with volume entry, the direction seems to be up
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.